Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth

References

• Lain KY, Catalano PM. Factors that affect maternal insulin resistance and modify fetal growth and body composition. Metab Syndr Relat Disord 2006;4:91–100
   PubMedGoogle Scholar
• Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991;165:1667–72
   PubMed Web of Science ®Google Scholar
• Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med 2008;21:149–57
   PubMed Web of Science ®Google Scholar
• Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195:40–9
   PubMed Web of Science ®Google Scholar
• Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009;16:921–37
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463–8
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:E769–78
   Web of Science ®Google Scholar
• Zhang C, Ding Z, Lv G, et al. Lower irisin level in patients with type 2 diabetes mellitus: a case-control study and meta-analysis. J Diabetes 2016;8:56–62
   PubMed Web of Science ®Google Scholar
• Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab 2013;98:4899–907
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: a renaissance in metabolism? Metab Clin Exp. 2013;62:1037–44
   PubMed Web of Science ®Google Scholar
• Garcés MF, Peralta JJ, Ruiz-Linares CE, et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia. J Clin Endocrinol Metab 2014;99:2113–19
   PubMed Web of Science ®Google Scholar
• Baka S, Malamitsi-Puchner A, Boutsikou T, et al. Cord blood irisin at the extremes of fetal growth. Metab Clin Exp 2015;64:1515–20
   PubMed Web of Science ®Google Scholar
• Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 1995;6:168–74
   PubMed Web of Science ®Google Scholar
• Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know. Curr Opin Obstet Gynecol 2009;21:521–6
   PubMed Web of Science ®Google Scholar
• Stengel A, Hofmann T, Goebel-Stengel M, et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013;39:125–30
   PubMed Web of Science ®Google Scholar
• Zhao L, Li J, Li ZL, et al. Circulating irisin is lower in gestational diabetes mellitus. Endocr J 2015;62:921–6
   PubMed Web of Science ®Google Scholar
• Kuzmicki M, Telejko B, Lipinska D, et al. Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol 2014;30:636–9
   PubMed Web of Science ®Google Scholar
• Yuksel MA, Oncul M, Tuten A, et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res Clin Pract 2014;104:171–5
   PubMed Web of Science ®Google Scholar
• Ebert T, Stepan H, Schrey S, et al. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine 2014;65:153–8
   PubMed Web of Science ®Google Scholar
• Piya MK, Harte AL, Sivakumar K, et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab 2014;306:E512–8
   PubMed Web of Science ®Google Scholar
• Çağlar M, Göksu M, Isenlik BS, et al. Irisin in idiopathic foetal growth restriction. J Endocrinol Invest 2014;37:619–24
   PubMed Web of Science ®Google Scholar
• Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene? Nature 2012;488:E9–E10
   PubMed Web of Science ®Google Scholar
• Henson MC, Castracane VD. Leptin in pregnancy: an update. Biol Reprod 2006;74:218–29
   PubMed Web of Science ®Google Scholar
• Bastian LA, West NA, Corcoran C, Munger RG, Cache County Study on Memory, Health, and Aging. Number of children and the risk of obesity in older women. Prev Med 2005;40:99–104
   PubMed Web of Science ®Google Scholar
• Luoto R, Mannisto S, Raitanen J. Ten-year change in the association between obesity and parity: results from the National FINRISK population study. Gend Med 2011;8:399–406
   PubMedGoogle Scholar
• Kritz-Silverstein D, Barrett-Connor E, Wingard DL. The effect of parity on the later development of non-insulin dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med 1989;321:1214–19
   PubMed Web of Science ®Google Scholar
• Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 2005;152:491–9
   PubMed Web of Science ®Google Scholar
• Wu Y, Song P, Zhang W, et al. Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nat Med 2015;21:373–82
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Anastasilakis AD, et al. Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease. Endocrine 2015;49:560–2
   PubMed Web of Science ®Google Scholar
• Aronis KN, Moreno M, Polyzos SA, et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes (Lond) 2015;39:156–61
   PubMed Web of Science ®Google Scholar